IP Library Granted Patent US 12,500,002
Granted Patent B2
US 12,500,002 · App. 18/101,913 · Granted Dec 16, 2025

Long term HbA1c prediction

Inventors: Marwa K. Qaraqe (Doha, QA); Md Shafiqul Islam (Doha, QA); Samir Brahim Belhaouari (Doha, QA); Goran Petrovski (Doha, QA)
Assignees: HAMAD BIN KHALIFA UNIVERSITY; SIDRA MEDICAL AND RESEARCH CENTER
G16H50/50G16H20/10G16H50/70
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,500,002
App. No.
18/101,913
Granted
Dec 16, 2025
Kind
B2
Abstract

Provided are methods of predicting HbA1c values.

Claims (30)

1 . A method for predicting HbA1c values comprising:

collecting HbA1c time series data of a patient across a plurality of days at a plurality of times for each day of the plurality of days;

converting the HbA1c time series data into a histogram image formatted to indicate a distribution of numerical values in HbA1c time series data organized by a number of days in the plurality of days as a first coordinate in the histogram image and a bin into which a given numerical value of the numerical values in the HbA1c time series data is classified as a second coordinate in the histogram image;

analyzing the image using a convolutional neural network;

predicting a predicted HbA1c level for the patient at a future time point; and

in response to the predicted HbA1c level for the patient being greater than or equal to a predefined threshold at the future time point, prescribing a treatment plan for the patient for administration of a therapeutic agent before the future time point.

2 . The method of claim 1 , wherein the predefined threshold is 6.5.

3 . The method of claim 1 , wherein the therapeutic agent administered according to the treatment plan comprises metformin.

4 . The method of claim 1 , wherein the therapeutic agent administered according to the treatment plan comprises insulin.

5 . A method for evaluating diabetes progression comprising:

collecting HbA1c time series data of a patient across a plurality of days at a plurality of times for each day of the plurality of days;

converting the HbA1c time series data into an image that represents the HbA1c time series data organized using timing of when individual values in the HbA1c time series data as a first coordinate in the image;

analyzing the image using a convolutional neural network;

predicting a predicted HbA1c level for the patient at a future time point; and

in response to the predicted HbA1c level for the patient being greater than or equal to a predefined threshold at the future time point, prescribing a treatment plan for the patient for administration of a therapeutic agent before the future time point.

6 . The method of claim 5 , wherein the future time point is at least one week in the future from predicting the predicted HbA1c level.

7 . The method of claim 5 , wherein the future time point is at least two weeks in the future from predicting the predicted HbA1c level.

8 . The method of claim 5 , wherein the future time point is at least three weeks in the future from predicting the predicted HbA1c level.

9 . The method of claim 5 , wherein the future time point is at least four weeks in the future from predicting the predicted HbA1c level.

10 . The method of claim 5 , wherein the image is a binary image formatted to indicate a count of measurements in the HbA1c time series data that are organized by which day in the plurality of days the measurements in the HbA1c time series data were collected on as the first coordinate in the binary image and which range of a plurality of a ranges of values that a given measurement of the measurements in the HbA1c time series data is categorized into as a second coordinate in the binary image.

11 . The method of claim 5 , wherein the image is a histogram image, formatted to indicate a distribution of numerical values in the HbA1c time series data organized by a number of days in the plurality of days as the first coordinate in the histogram image and a bin into which a given numerical value of the numerical values in the HbA1c time series data is classified as a second coordinate in the histogram image.

12 . The method of claim 5 , wherein every address in the image according to pairings of the first coordinate and a second coordinate is populated with a color value based on the HbA1c time series data as organized in the image.

13 . A method, comprising:

collecting HbA1c time series data of a patient across a plurality of days at a plurality of times for each day of the plurality of days;

converting the HbA1c time series data into a binary image formatted to indicate a count of measurements in the HbA1c time series data that are organized by which day in the plurality of days the measurements in the HbA1c time series data were collected on as a first coordinate in the binary image and which range of a plurality of a ranges of values that a given measurement of the measurements in the HbA1c time series data are categorized into as a second coordinate in the binary image;

analyzing the binary image using a convolutional neural network;

predicting a predicted HbA1c level for the patient at a future time point at least one week in the future; and

in response to the predicted HbA1c level for the patient being greater than a predefined threshold, prescribing a treatment plan for the patient of at least one of metformin administration and insulin administration before the future time point.

14 . The method of claim 13 , wherein the plurality of days consists of fourteen days of continuous blood glucose (CGM) measurements from the patient.

15 . The method of claim 13 , wherein the HbA1c time series data is collected at fifteen minute intervals from the patient.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2025
From: QATAR FOUNDATION FOR EDUCATION, SCIENCE & COMMUNITY DEVELOPMENT
To: HAMAD BIN KHALIFA UNIVERSITY
Reel/Frame 069936/0656 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2023
From: QARAQE, MARWA K.; ISLAM, MD SHAFIQUL; BELHAOUARI, SAMIR BRAHIM; PETROVSKI, GORAN
To: QATAR FOUNDATION FOR EDUCATION, SCIENCE AND COMMUNITY DEVELOPMENT; SIDRA MEDICAL AND RESEARCH CENTER
Reel/Frame 064864/0442 →
Continuity (2)
Provisional Application 63303291 · Jan 26, 2022
Related Publication 20230238147A1 · Jul 27, 2023
References Cited (7)
US 20170014495A1 · Sarangarajan · 2017 [cited by examiner]
US 20200164209A1 · Hogg · 2020 [cited by examiner]
US 20240242834A1 · Deng · 2024 [cited by examiner]
EP 3477589A1 · 2019 [cited by examiner]
Wong, et al.; “The Correslation between Hemoglobin A1c (HbA1c) and Hyperreflective Dots (HRD) in Diabetic Patients”; International Journal of Environmental Research and Public Health; May 1, 2020; (11 pages). [cited by applicant]
Lopez, et al.; “Retinal Image Analysis to Detect and Quantify Lesions Associated With Diabetic Retinopathy”; Investigative Ophthalmology & Visual Science; vol. 44, 3977; May 2003; (2 pages). [cited by applicant]
Salz, et al; “Imaging in Diabetic Retinopathy”; Middle East African Journal of Ophthalmology; Apr. 2015; (13 pages). [cited by applicant]